Gland Pharma shares zoom 20% as Q1 growth triggers upgrades

Global brokerage firm Jefferies upgraded Gland Pharma’s stock to buy from underperform with an increased price target of Rs 1,640 from Rs 1,065 earlier. Bernstein also gave an outperform rating on Gland Pharma, saying that the Q1 numbers point towards early signs of revival in base business.

Generated by Feedzy